Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study
2001

Cancer Risk in Patients with Dermatomyositis or Polymyositis

Sample size: 705 publication Evidence: moderate

Author Information

Author(s): Stockton D, Doherty V R, Brewster D H

Primary Institution: Scottish Cancer Intelligence Unit, Information & Statistics Division

Hypothesis

Patients with dermatomyositis or polymyositis have an elevated risk of developing cancer.

Conclusion

Patients with dermatomyositis and polymyositis have significantly increased risks of certain cancers, particularly shortly after diagnosis.

Supporting Evidence

  • 50 patients with dermatomyositis developed a first malignancy.
  • 40 patients with polymyositis developed a first malignancy.
  • Significantly elevated risks were observed for lung, cervix uteri, and ovarian cancer in patients with dermatomyositis.
  • Hodgkin’s disease risk was elevated in patients with polymyositis.
  • The excess risk of cancer was highest around the time of diagnosis.

Takeaway

People with certain muscle diseases are more likely to get cancer, especially soon after they find out they have the disease.

Methodology

A national, retrospective population-based cohort study using hospital discharge, cancer registration, and death records.

Potential Biases

Potential biases in record linkage and retrospective data collection.

Limitations

The study is retrospective and may not account for all confounding factors.

Participant Demographics

Patients hospitalized with a first diagnosis of dermatomyositis or polymyositis in Scotland from 1982 to 1996.

Statistical Information

Confidence Interval

95% CI 5.7–10.1 for DM, 1.5–2.9 for PM

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.2001.1699

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication